Meanwhile, Met@Man-MPs markedly reshaped the tumor immune microenvironment, as evidenced by the increased M1-like TAM percentages (Fig. 10b), the decreased M2-like TAM percentages (Fig. 10c), and the enhanced infiltration and activation of CD8+ T cells (Fig. 10d–g) in tumor tissues. This evidence concerns the gene CD8A and neoplasm.